“A few European countries hit us every year with big price cuts. I’m not terrified,” says Andrew Witty, chief executive of GlaxoSmithKline.
via ft.com
Noël Renaudin, an official in France’s health ministry, has a tough message for the pharmaceutical companies with which he regularly negotiates: “We have to stop the infinite growth in prices for drugs. It’s no longer reasonable.”
His hardening attitude reflects a trend across Europe, where long-standing concern about rising healthcare costs is being translated into aggressive action following the financial crisis and the euro’s recent troubles.
No comments:
Post a Comment